Genome Editing
Genome editing with engineered nucleases (GEEN) is emergent type of Genetic Engineering. GEEN is the technology in which DNA is inserted, deleted or replaced in the genome. The emergence of highly versatile genome-editing technologies has provided investigators with the ability to rapidly and economically introduce sequence-specific modifications into the genomes of a broad spectrum of cell types and organisms. It also promotes various changes in sub cellular level. Genome Editing itself also holds tremendous potential for treating the underlying various idiopathic genetic causes of certain diseases. The core technologies now most commonly used techniques to facilitate genome editing are clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR-associated protein 9 (Cas9), transcription activator-like effector nucleases (TALENs), zinc-finger nucleases (ZFNs), and homing endonucleases or mega nucleases.
- Detecting conditions
- Adult genetics
- ART/Infertility genetics
- ART/Infertility genetics
- Cardiovascular genetics
- Hereditary cancer genetics
- Neurogenetics
- Pediatric genetics
- Prenatal genetics
- Stem cell and cellular therapies
- Cell therapy: clinical trials
- Paediatrics’ and Genetics
- Market and Future Prospects of Gene Therapy
- Gene Editing and CRISPR Based Technologies
Related Conference of Genome Editing
21th World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research
16th International Conference on Human Genetics and Genetic Diseases
19th International Conference on Genomics & Pharmacogenomics
Genome Editing Conference Speakers
Recommended Sessions
- Advanced Gene Therapeutics
- Cancer cells & Biomarkers
- Cancer Genetics
- Cell and Gene Therapy for Rare & Common Diseases
- Cell Science and Stem Cell Research
- Clinical Trials on Cell & Gene Therapy
- Gene Therapy
- Genetic Disorders
- Genetics
- Genetics & Genomic Medicine
- Genome Editing
- Genome Integrity
- Human Genetics
- Nano Therapy
- Pediatrics and Genetics
- Viral Gene Therapy
Related Journals
Are you interested in
- Artificial Intelligence and Computational Biology in Regenerative Medicine - Stemgen 2026 (France)
- Biomaterials and Nanotechnology in Regenerative Medicine - Stemgen 2026 (France)
- Cancer Stem Cells and Oncology - Stemgen 2026 (France)
- Cardiovascular Regeneration - Stemgen 2026 (France)
- Clinical Trials and Translational Stem Cell Research - Stemgen 2026 (France)
- Ethical, Legal, and Social Implications in Stem Cell Research - Stemgen 2026 (France)
- Future Trends: Organoids, Bioengineering, and Next-Generation Therapies - Stemgen 2026 (France)
- Gene Editing and CRISPR Technologies - Stemgen 2026 (France)
- Induced Pluripotent Stem Cells (iPSCs) and Reprogramming - Stemgen 2026 (France)
- Mesenchymal Stem Cells (MSCs) in Therapy - Stemgen 2026 (France)
- Regenerative Dentistry and Craniofacial Applications - Stemgen 2026 (France)
- Regenerative Medicine and Tissue Engineering - Stemgen 2026 (France)
- Stem Cell Banking and Cryopreservation - Stemgen 2026 (France)
- Stem Cell Biology and Cellular Mechanisms - Stemgen 2026 (France)
- Stem Cells in Neurological and Neurodegenerative Disorders - Stemgen 2026 (France)
